| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 46.3182 | 34 |
| GSM780708 | Untreated after 4 days (C2_1) | 54.6746 | 59 |
| GSM780709 | Untreated after 4 days (C3_1) | 52.8474 | 56 |
| GSM780719 | Untreated after 4 days (C1_2) | 42.8785 | 17 |
| GSM780720 | Untreated after 4 days (C2_2) | 45.3005 | 29 |
| GSM780721 | Untreated after 4 days (C3_2) | 48.9889 | 45 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 46.2929 | 33 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 48.6047 | 44 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 46.379 | 34 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 48.9943 | 45 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 48.2624 | 42 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 52.6423 | 55 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 44.1856 | 23 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 44.6112 | 25 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 46.1061 | 33 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 47.3097 | 38 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 48.5043 | 43 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 49.1614 | 46 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 45.5671 | 30 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 50.6559 | 50 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 40.3015 | 7 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 46.6835 | 35 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 47.3234 | 38 |